Literature DB >> 12578976

Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion.

Dilprit Bagga1, Ling Wang, Robin Farias-Eisner, John A Glaspy, Srinivasa T Reddy.   

Abstract

Omega-6 (omega-6) polyunsaturated fatty acids (PUFA), abundant in the Western diet, are precursors for a number of key mediators of inflammation including the 2-series of prostaglandins (PG). PGE(2), a cyclooxygenase (COX) metabolite of arachidonic acid, a omega-6 PUFA, is a potent mediator of inflammation and cell proliferation. Dietary supplements rich in omega-3 PUFA reduce the concentrations of 2-series PG and increase the synthesis of 3-series PG (e.g., PGE(3)), which are believed to be less inflammatory. However, studies on cellular consequences of increases in 3-series PG in comparison to 2-series PG have not been reported. In this study, we compared the effects of PGE(2) and PGE(3) on (i) cell proliferation in NIH 3T3 fibroblasts, (ii) expression and transcriptional regulation of the COX-2 gene in NIH 3T3 fibroblasts, and (iii) the production of an inflammatory cytokine, IL-6, in RAW 264.7 macrophages. PGE(3), unlike PGE(2), is not mitogenic to NIH 3T3 fibroblasts. PGE(2) and PGE(3) both induce COX-2 mRNA via similar signaling mechanisms; however, compared with PGE(2), PGE(3) is significantly less efficient in inducing COX-2 gene expression. Furthermore, although both PGE(2) and PGE(3) induce IL-6 synthesis in RAW 264.7 macrophages, PGE(3) is substantially less efficient compared with PGE(2). We further show that increasing the omega-3 content of membrane phospholipid results in a decrease in mitogen-induced PGE(2) synthesis. Taken together, our data suggest that successful replacement of omega-6 PUFA with omega-3 PUFA in cell membranes can result in a decreased cellular response to mitogenic and inflammatory stimuli.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12578976      PMCID: PMC149905          DOI: 10.1073/pnas.0334211100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

Review 1.  Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes.

Authors:  S L Tilley; T M Coffman; B H Koller
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

2.  Transcriptional regulation of the cyclooxygenase-2 gene in activated mast cells.

Authors:  S T Reddy; D J Wadleigh; H R Herschman
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

3.  Interleukin-6 synthesis induced by prostaglandin E2: cross-talk regulation by protein kinase C.

Authors:  O Kozawa; A Suzuki; H Tokuda; T Kaida; T Uematsu
Journal:  Bone       Date:  1998-04       Impact factor: 4.398

Review 4.  Importance of n-3 fatty acids in health and disease.

Authors:  W E Connor
Journal:  Am J Clin Nutr       Date:  2000-01       Impact factor: 7.045

5.  Transcriptional regulation of the cyclooxygenase-2 gene by diverse ligands in murine osteoblasts.

Authors:  D J Wadleigh; H R Herschman
Journal:  Biochem Biophys Res Commun       Date:  1999-11-02       Impact factor: 3.575

6.  Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma.

Authors:  S Gupta; M Srivastava; N Ahmad; D G Bostwick; H Mukhtar
Journal:  Prostate       Date:  2000-01       Impact factor: 4.104

7.  Modulation of omega-3/omega-6 polyunsaturated ratios with dietary fish oils in men with prostate cancer.

Authors:  W J Aronson; J A Glaspy; S T Reddy; D Reese; D Heber; D Bagga
Journal:  Urology       Date:  2001-08       Impact factor: 2.649

Review 8.  Molecular pathology of cyclooxygenase-2 in neoplasia.

Authors:  E Fosslien
Journal:  Ann Clin Lab Sci       Date:  2000-01       Impact factor: 1.256

9.  Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer.

Authors:  O N Tucker; A J Dannenberg; E K Yang; F Zhang; L Teng; J M Daly; R A Soslow; J L Masferrer; B M Woerner; A T Koki; T J Fahey
Journal:  Cancer Res       Date:  1999-03-01       Impact factor: 12.701

10.  Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer.

Authors:  D Hwang; D Scollard; J Byrne; E Levine
Journal:  J Natl Cancer Inst       Date:  1998-03-18       Impact factor: 13.506

View more
  180 in total

1.  The activation of supraspinal GPR40/FFA1 receptor signalling regulates the descending pain control system.

Authors:  K Nakamoto; T Nishinaka; N Sato; F Aizawa; T Yamashita; M Mankura; Y Koyama; F Kasuya; S Tokuyama
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

2.  Effect of cyclooxygenase genotype and dietary fish oil on colonic eicosanoids in mice.

Authors:  Andrew P Neilson; Zora Djuric; Jianwei Ren; Yu H Hong; Ananda Sen; Corey Lager; Yan Jiang; Shony Reuven; William L Smith; Dean E Brenner
Journal:  J Nutr Biochem       Date:  2011-09-19       Impact factor: 6.048

3.  JS-K, a nitric oxide-releasing prodrug, induces breast cancer cell death while sparing normal mammary epithelial cells.

Authors:  Vanity McMurtry; Joseph E Saavedra; René Nieves-Alicea; Ann-Marie Simeone; Larry K Keefer; Ana M Tari
Journal:  Int J Oncol       Date:  2011-01-25       Impact factor: 5.650

Review 4.  Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation.

Authors:  Yeon-Joo Kang; Uri R Mbonye; Cynthia J DeLong; Masayuki Wada; William L Smith
Journal:  Prog Lipid Res       Date:  2007-01-18       Impact factor: 16.195

Review 5.  Treatment of parenteral nutrition-associated liver disease: the role of lipid emulsions.

Authors:  Prathima Nandivada; Sarah J Carlson; Melissa I Chang; Eileen Cowan; Kathleen M Gura; Mark Puder
Journal:  Adv Nutr       Date:  2013-11-06       Impact factor: 8.701

Review 6.  Prostaglandin E3 metabolism and cancer.

Authors:  Peiying Yang; Yan Jiang; Susan M Fischer
Journal:  Cancer Lett       Date:  2014-03-18       Impact factor: 8.679

7.  Marked elevations in pro-inflammatory polyunsaturated fatty acid metabolites in females with irritable bowel syndrome.

Authors:  Gerard Clarke; Peter Fitzgerald; Alan A Hennessy; Eugene M Cassidy; Eamonn M M Quigley; Paul Ross; Catherine Stanton; John F Cryan; Timothy G Dinan
Journal:  J Lipid Res       Date:  2009-11-11       Impact factor: 5.922

8.  Fish oil and indomethacin in combination potently reduce dyslipidemia and hepatic steatosis in LDLR(-/-) mice.

Authors:  Ganesan Murali; Ginger L Milne; Corey D Webb; Ann B Stewart; Ryan P McMillan; Brandon C Lyle; Matthew W Hulver; Viswanathan Saraswathi
Journal:  J Lipid Res       Date:  2012-07-29       Impact factor: 5.922

9.  Impact of supplementing preoperative intravenous omega 3 Fatty acids in fish oil on immunomodulation in elderly patients undergoing hip surgery.

Authors:  Ramachandran Gopinath; Sreekanth Yelliboina; Madhavi Singh; V B N Prasad
Journal:  Indian J Surg       Date:  2012-06-19       Impact factor: 0.656

10.  Transgenic mice enriched in omega-3 fatty acids are more susceptible to pulmonary tuberculosis: impaired resistance to tuberculosis in fat-1 mice.

Authors:  Diana L Bonilla; Yang-Yi Fan; Robert S Chapkin; David N McMurray
Journal:  J Infect Dis       Date:  2010-02-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.